Sponsor:
Boehringer Ingelheim
Code:
NCT07855900
Conditions
Obesity
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Survodutide
Brief summary:
Conditions
Obesity
Study ID
NCT07855900
Start date
Nov 25, 2026
Status verified date
Nov, 2026
Completion date
Nov 6, 2029
Anticipated
Primary completion date
Nov 6, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
350 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: SWITCH cohort
experimental: INITIATION cohort
Interventions
Survodutide
Primary outcome measure
Central contacts
Locations
The Center for Diabetes and Endocrine Care
Recruiting
Fort Lauderdale, Florida, United States, 33312
Contacts
Flourish Research
Recruiting
Merritt Island, Florida, United States, 32952
Contacts
Sponsor
Boehringer Ingelheim
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Boehringer Ingelheim on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.